
CAS 2024548-03-4
:Formule :C31H29N5O7
InChI :InChI=1S/C31H29N5O7/c1-31(2)24-18-32-35(22-10-8-21(9-11-22)29(37)38)28(24)23-16-26(36(40)41)25(17-27(23)43-31)33-12-14-34(15-13-33)30(39)42-19-20-6-4-3-5-7-20/h3-11,16-18H,12-15,19H2,1-2H3,(H,37,38)
Code InChI :GBHKWXUSQTVIBN-UHFFFAOYSA-N
SMILES :CC1(C2=C(C3=CC(=C(C=C3O1)N4CCN(CC4)C(=O)OCC5=CC=CC=C5)[N+](=O)[O-])N(N=C2)C6=CC=C(C=C6)C(=O)O)C
Filtrer par
Pourcentage de pureté
0
100
|
0
|
50
|
90
|
95
|
100
7 produits trouvés.
- Tri par prix ascendant
- Tri par prix descendant
- Puretés inférieures
- Puretés supérieures
- Livraison estimée la plus rapide
4-(7-(4-((Benzyloxy)carbonyl)piperazin-1-yl)-4,4-dimethyl-8-nitrochromeno[4,3-c]pyrazol-1(4H)-yl)benzoic acid
CAS :4-(7-(4-((Benzyloxy)carbonyl)piperazin-1-yl)-4,4-dimethyl-8-nitrochromeno[4,3-c]pyrazol-1(4H)-yl)benzoic acidFormule :C31H29N5O7Degré de pureté :99%Masse moléculaire :583.59Lin28-let-7a antagonist 1
CAS :Lin28-let-7a antagonist 1Formule :C31H29N5O7Degré de pureté :≥98%Masse moléculaire :583.59Lin28-let-7a antagonist 1
CAS :Lin28-let-7a antagonist 1, with an IC50 of 4.03 μM for Lin28A-let-7a-1 interaction,and shows a clear antagonistic effect against the Lin28-let-7a interaction.Formule :C31H29N5O7Degré de pureté :99.44%Couleur et forme :SolidMasse moléculaire :583.5913Ref: IN-DA01JQUC
1mg161,00€5mg192,00€10mg276,00€25mg618,00€50mg768,00€100mg998,00€250mg1.496,00€1g3.813,00€Lin28-let-7a antagonist 1
CAS :4-(7-(4-((Benzyloxy)carbonyl)piperazin-1-yl)-4,4-dimethyl-8-nitrochromeno[4,3-c]pyrazol-1(4H)-yl)benzoic acidFormule :C31H29N5O7Degré de pureté :99%Masse moléculaire :583.594-(7-(4-((Benzyloxy)carbonyl)piperazin-1-yl)-4,4-dimethyl-8-nitrochromeno[4,3-c]pyrazol-1(4H)-yl)benzoic acid
CAS :Degré de pureté :99%Masse moléculaire :583.6010132Ref: 10-F867157
1gÀ demander10mgÀ demander25mgÀ demander50mgÀ demander100mgÀ demander250mgÀ demander5mg186,00€Lin28-let-7a antagonist 1
CAS :Lin28-let-7a antagonist 1 is a small molecule inhibitor, which is a chemically synthesized compound with significant therapeutic potential. It acts by targeting the Lin28/let-7 axis, a critical regulatory pathway involved in cellular processes such as development, metabolism, and tumorigenesis. The source of this antagonist is a synthetic, rationally designed compound, optimized for high specificity and potency.
Formule :C31H29N5O7Degré de pureté :Min. 95%Masse moléculaire :583.59 g/mol





